More recently, we have verified that mice with DSS induced experimental colitis are characterized with both promoted metabolic excretion and increased de-novo hepatic synthesis of BAs, initiated by the activated intestinal PPARα-UGTs and compromised FXR-FGF15 signaling [25]. This evidence concerns the gene NR1H4 and colitis.